A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

M.C. Fargnoli; M. Esposito; S. Ferrucci; G. Girolomoni; A. Offidani; A. Patrizi; K. Peris; A. Costanzo; G. Malara; G. Pellacani; M. Romanelli; P. Amerio; A. Cristaudo; M.L. Flori; A. Motolese; P. Betto; C. Patruno; P. Pigatto; C. Peccianti; G. Stinco; I. Zalaudek; L. Bianchi; V. Boccaletti; S.P. Cannavo; F. Cusano; S. Lembo; R. Mozzillo; R. Gallo; C. Potenza; F. Rongioletti; R. Tiberio; T. Grieco; G. Micali; S. Persechino; M. Pettinato; S. Pucci; L. Stingeni; C. Caruso; G. Argenziano; On behalf of the Dupilumab Italian National Access Program (Dup-INAP Group)

doi:10.1080/09546634.2020.1773379

A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

M.C. Fargnoli, M. Esposito, S. Ferrucci, G. Girolomoni, A. Offidani, A. Patrizi, K. Peris, A. Costanzo, G. Malara, G. Pellacani, M. Romanelli, P. Amerio, A. Cristaudo, M.L. Flori, A. Motolese, P. Betto, C. Patruno, P. Pigatto, C. Peccianti, G. StincoI. Zalaudek, L. Bianchi, V. Boccaletti, S.P. Cannavo, F. Cusano, S. Lembo, R. Mozzillo, R. Gallo, C. Potenza, F. Rongioletti, R. Tiberio, T. Grieco, G. Micali, S. Persechino, M. Pettinato, S. Pucci, L. Stingeni, C. Caruso, G. Argenziano, On behalf of the Dupilumab Italian National Access Program (Dup-INAP Group)

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of Dermatological Treatment
DOIs	https://doi.org/10.1080/09546634.2020.1773379
Publication status	Published - 2020

Access to Document

10.1080/09546634.2020.1773379

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087613595&doi=10.1080%2f09546634.2020.1773379&partnerID=40&md5=0cae995caccb86722894635ed0e724e4

Cite this

Fargnoli, M. C., Esposito, M., Ferrucci, S., Girolomoni, G., Offidani, A., Patrizi, A., Peris, K., Costanzo, A., Malara, G., Pellacani, G., Romanelli, M., Amerio, P., Cristaudo, A., Flori, M. L., Motolese, A., Betto, P., Patruno, C., Pigatto, P., Peccianti, C., ... Group), O. B. O. T. D. I. N. A. P. (2020). A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. Journal of Dermatological Treatment. https://doi.org/10.1080/09546634.2020.1773379

Fargnoli, MC, Esposito, M, Ferrucci, S, Girolomoni, G, Offidani, A, Patrizi, A, Peris, K , Costanzo, A, Malara, G, Pellacani, G, Romanelli, M, Amerio, P, Cristaudo, A, Flori, ML, Motolese, A, Betto, P, Patruno, C, Pigatto, P, Peccianti, C, Stinco, G, Zalaudek, I, Bianchi, L, Boccaletti, V, Cannavo, SP, Cusano, F, Lembo, S, Mozzillo, R, Gallo, R, Potenza, C, Rongioletti, F, Tiberio, R, Grieco, T, Micali, G, Persechino, S, Pettinato, M, Pucci, S, Stingeni, L, Caruso, C, Argenziano, G & Group), OBOTDINAP 2020, 'A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis', Journal of Dermatological Treatment. https://doi.org/10.1080/09546634.2020.1773379

@article{f8ae3dca831e49c282c6c3f31786e6c6,

title = "A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis",

author = "M.C. Fargnoli and M. Esposito and S. Ferrucci and G. Girolomoni and A. Offidani and A. Patrizi and K. Peris and A. Costanzo and G. Malara and G. Pellacani and M. Romanelli and P. Amerio and A. Cristaudo and M.L. Flori and A. Motolese and P. Betto and C. Patruno and P. Pigatto and C. Peccianti and G. Stinco and I. Zalaudek and L. Bianchi and V. Boccaletti and S.P. Cannavo and F. Cusano and S. Lembo and R. Mozzillo and R. Gallo and C. Potenza and F. Rongioletti and R. Tiberio and T. Grieco and G. Micali and S. Persechino and M. Pettinato and S. Pucci and L. Stingeni and C. Caruso and G. Argenziano and Group), {On behalf of the Dupilumab Italian National Access Program (Dup-INAP}",

note = "Cited By :3 Export Date: 26 February 2021",

year = "2020",

doi = "10.1080/09546634.2020.1773379",

language = "English",

journal = "Journal of Dermatological Treatment",

issn = "0954-6634",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

AU - Fargnoli, M.C.

AU - Esposito, M.

AU - Ferrucci, S.

AU - Girolomoni, G.

AU - Offidani, A.

AU - Patrizi, A.

AU - Peris, K.

AU - Costanzo, A.

AU - Malara, G.

AU - Pellacani, G.

AU - Romanelli, M.

AU - Amerio, P.

AU - Cristaudo, A.

AU - Flori, M.L.

AU - Motolese, A.

AU - Betto, P.

AU - Patruno, C.

AU - Pigatto, P.

AU - Peccianti, C.

AU - Stinco, G.

AU - Zalaudek, I.

AU - Bianchi, L.

AU - Boccaletti, V.

AU - Cannavo, S.P.

AU - Cusano, F.

AU - Lembo, S.

AU - Mozzillo, R.

AU - Gallo, R.

AU - Potenza, C.

AU - Rongioletti, F.

AU - Tiberio, R.

AU - Grieco, T.

AU - Micali, G.

AU - Persechino, S.

AU - Pettinato, M.

AU - Pucci, S.

AU - Stingeni, L.

AU - Caruso, C.

AU - Argenziano, G.

AU - Group), On behalf of the Dupilumab Italian National Access Program (Dup-INAP

N1 - Cited By :3 Export Date: 26 February 2021

PY - 2020

Y1 - 2020

U2 - 10.1080/09546634.2020.1773379

DO - 10.1080/09546634.2020.1773379

M3 - Article

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

ER -